Market Tracker

07/28 6:05pm ET

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

45.91
Data as of Jul 28
 +0.94 / +2.09%
Today’s Change
31.32
Today|||52-Week Range
47.93
+11.89%
Year-to-Date
RDY Regular Dividend: RDY will begin trading ex-dividend on 08/01/14 with a $0.3034 dividend payable to shareholders of record as of 07/11/14.

Today’s Trading

Previous close44.97
Today’s open45.63
Day’s range45.41 - 45.98
Volume277,294
Average volume (3 months)353,436
Market cap$7.7B
Dividend yield0.53%
Data as of 4:02pm ET, 07/28/2014

Growth & Valuation

Earnings growth (last year)+14.93%
Earnings growth (this year)--
Earnings growth (next 5 years)+18.97%
Revenue growth (last year)+2.04%
P/E ratio--
Price/Sales3.43
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+3.68+3.51%
INCYIncyte Corp-0.16-0.34%
SLXPSalix Pharmaceutical...-0.90-0.68%
JAZZJazz Pharmaceuticals...-5.70-4.00%
Data as of 4:00pm ET, 07/28/2014

Financials

Next reporting dateJuly 30, 2014
EPS forecast (this quarter)$0.51
Annual revenue (last year)$2.2B
Annual profit (last year)$354.8M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-Human Resources
Saumen Chakraborty
Corporate headquarters
Hyderabad, Andhra Pradesh

Forecasts